touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events.

The multidisciplinary team:

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team review the role of biomarkers in informing immune checkpoint inhibitor use across tumour types.

The multidisciplinary team

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events.

The multidisciplinary team:

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-in-solid-tumours/

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the current and upcoming indications for immune checkpoint inhibitors in patients with solid tumours and review general considerations for their use.

The multidisciplinary team:

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-in-solid-tumours/

touchPANEL DISCUSSION for touchONCOLOGY

Listen to an oncologist, urologist and nurse discuss adverse event identification and management with immunotherapies and targeted therapies for locally advanced or metastatic urothelial carcinoma. 

The experts:

• Dr Axel Merseburger, University Hospital Schleswig-Holstein, Campus Lübeck, Germany

This touchPODCAST is for HCPs outside the US only. 

This activity is funded by an independent medical education grant from Astellas Inc. and Seagen Inc., and is jointly provided by USF Health and touchIME.

For further information please visit: https://touchoncologyime.org/adverse-event-identification-and-management-in-locally-advanced-metastatic-urothelial-carcinoma

touchIN CONVERSATION for touchINFECTIOUS DISEASES

Listen to Dr Farhan Fazal (Sheikh Khalifa Medical City Hospital, Abu Dhabi, UAE) in conversation with Dr Nada Melhem (American University of Beirut, Beirut, Lebanon). They respond to questions submitted by the HCP audience and provide their expert insights on COVID-19 vaccination challenges and strategies for improving vaccine uptake in the Middle East.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Moderna, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchinfectiousdiseasesime.org/in-conversation-practical-considerations-covid19-vaccination-middle-east/

touchEXPERT OPINIONS for touchENDOCRINOLOGY

In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology.

The experts:

• Dr Stephen Graves, University of Iowa, Iowa City, IA, USA

This touchPODCAST is for HCPs only.

 This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.

For further information visit: https://touchendocrinologyime.org/radiopharmaceuticals-adult-oncology-primer/

touchEXPERT OPINIONS for touchONCOLOGY

In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology.

The experts:

• Dr Stephen Graves, University of Iowa, Iowa City, IA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A. This activity is jointly provided by USF Health and touchIME.

For further information visit: https://touchoncologyime.org/radiopharmaceuticals-adult-oncology-primer/ 

touchIN CONVERSATION for touchINFECTIOUS DISEASES

Listen to Dr John Amuasi (Kwame Nkrumah University of Science and Technology, Kumasi, Ghana) in conversation with Dr Christina Obiero (Kenya Medical Research Institute, Kilifi, Kenya). They respond to questions submitted by the HCP audience and provide their expert insights on COVID-19 vaccination challenges and strategies for improving vaccine uptake in Africa.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Moderna, Inc. This activity was led by USF Health and touchIME. 

For further information visit our website: https://touchinfectiousdiseasesime.org/in-conversation-practical-considerations-covid19-vaccination-africa